🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elizabeth H. Stover

Dana-Farber Cancer Institute

ORCID: 0000-0002-6578-3216

Also affiliated with Dana-Farber/Harvard Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.6Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

Nature Medicine(2020)10.1038/s41591-020-0844-1
Top 4%
5.6DataRank
Top 4%819 citations

Caroline B. M. Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro +45 more

Papers

Driven by 11 papers — median percentile 96. Top paper: “A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors”.

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

Nature Medicine(2020)10.1038/s41591-020-0844-1
Top 4%
5.6DataRank
Top 4%819 citations

Caroline B. M. Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro +45 more

A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors

bioRxiv (Cold Spring Harbor Laboratory)(2019)10.1101/761429
N/A
2.5DataRank · unranked
68 citations

Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Indresh Singh +44 more

A single-cell landscape of high-grade serous ovarian cancer

Nature Medicine(2020)10.1038/s41591-020-0926-0
N/A
0.938DataRank · unranked
518 citations

Itay Tirosh, Elizabeth H. Stover, Isaac Wakiro, Michael S. Cuoco, Idan Alter +30 more

A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100974
N/A
0.416DataRank · unranked
15 citations

Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak +14 more

Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-X L degradation to overcome cancer chemoresistance

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.24.661170
N/A
0.373DataRank · unranked
11 citations

Adam Presser, Lissah Johnson, Yusuke Matoba, Brendan Shay, Weiyi Xu +19 more

Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2834
N/A
0DataRank · unranked
35 citations

Nabihah Tayob, Livius Penter, MacLean Sellars, Anna Tarren, Vipheaviny Chea +19 more

Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype

Journal of Clinical Investigation(2022)10.1172/jci155931
N/A
0DataRank · unranked
24 citations

Siyu Sun, Micayla N. Flores, Emily Berzolla, Eunae You, Ildiko E. Phillips +22 more

A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer

Nature Communications(2021)10.1038/s41467-021-25904-w
N/A
0DataRank · unranked
69 citations

Alexandre André Balieiro Anastácio da Costa, D. Gulhan, Elizabeth K. Lee, Su-Chun Cheng, Andrea E. Wahner Hendrickson +14 more

Randomized phase 2 study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: Final overall survival (OS) and biomarker analyses.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5512
N/A
0DataRank · unranked
6 citations

Elizabeth Katherine Lee, Su–Chun Cheng, Alexandre André Balieiro Anastácio da Costa, Andrea E. Wahner Hendrickson, D. Gulhan +14 more

A compendium of Amplification-Related Gain Of Sensitivity (ARGOS) genes in human cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.16.571980
N/A
0DataRank · unranked
2 citations

Michaël Schubert, Nicholas Khuu, Maria F. Suárez Peredo Rodríguez, Kaimeng Huang, Michelle Swift +21 more

Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21228690
N/A
0DataRank · unranked
31 citations

David L. Mayhew, Jonathan Rennhack, Jonathan So, Elizabeth H. Stover, Justin H. Hwang +2 more